Dutch ingredients company Corbion has partnered with Germany-based speciality enzymes provider BRAIN Biotech to develop advanced biobased antimicrobial compounds.
The partnership will enhance Corbion’s offerings in food preservation for manufacturers focused on natural ingredients.
It aims to advance sustainable preservation technologies in the food industry.
Under the collaboration, BRAIN Biotech will contribute its expertise in enzyme technology, microbial strain development, and bioprocess innovation.
Corbion will provide its knowledge in food systems, biobased preservation, and scaling capabilities for the partnership.
The collaboration seeks to harness the complementary strengths of both companies to push the boundaries of nature-based ingredient technology.
BRAIN Biotech managing director and executive vice president Martin Langer said: “We are very pleased to partner with Corbion in expanding what’s possible with sustainable, bio-based solutions.
“We see a very strong affinity between our team at BRAIN and our collaborators at Corbion.
“Given our respective strengths, shared vision, and complementary areas of expertise, we expect this to be a fruitful collaboration that will deliver real impact for the world’s food manufacturers.”
Recently, Corbion partnered with US-based Kuehnle AgroSystems for developing natural astaxanthin through non-GMO heterotrophic algae.
Astaxanthin, a carotenoid with antioxidant properties, is commonly sourced from chemically synthesised or algae-derived processes.
Under the collaboration, Corbion and Kuehnle will produce a fermentation-based alternative, enhancing its bioavailability and stability.
The new astaxanthin product will use Kuehnle’s fermentation technology and Corbion’s production expertise to achieve scalability.
Corbion global innovation vice president Domenico Vulcano said: “At Corbion, advancing the state of the art in nature-based ingredient technologies, proving and expanding on their value and efficacy, is essential to preserving what matters.
“One of the ways we continue to strengthen our investment in innovation is through establishing partnerships with other experts like those at BRAIN Biotech.
“We believe this kind of collaboration will help us bring the next paradigm-changing breakthroughs to market sooner.”
